ABBV vs BSX: Options Risk Comparison

AbbVie Inc. and BOSTON SCIENTIFIC CORP compared side by side — risk score, IV Rank, edge and earnings. Updated every 30 minutes.

Metric	ABBV	BSX
Risk Score	39	100
Risk Band	LOW	HIGH
IV Rank	74.8%	42.9%
IV %	31.2%	40.9%
Edge Score	+36	-57
Price Δ	+0.2%	+0.1%
Next Earnings	2026-07-30	2026-07-29
Sector	Health Care	Health Care

Which has higher options risk?

BOSTON SCIENTIFIC CORP (BSX) currently carries the higher options risk score (100 vs 39 for ABBV) — meaning more active catalysts that can drive an overnight move. For selling option premium, AbbVie Inc. (ABBV) has the better edge score (+36) — a stronger blend of high IV Rank and low risk.

Risk score (0–100) reflects active catalysts — earnings, legal, SEC filings and news. Edge score = IV Rank − risk score; higher is better for selling premium.

Run a full scan on each — free

Scan ABBV → Scan BSX →

ABBV risk pages

ABBV overview ABBV IV / options ABBV earnings BSX overview BSX IV / options BSX earnings

More Health Care comparisons

ABBV vs ABT ABBV vs A ABBV vs ALGN ABBV vs AMGN ABBV vs BAX ABBV vs BDX ABBV vs TECH ABBV vs BIIB

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer